ArticleArchives of virology2024

A synthetic TLR4 agonist significantly increases humoral immune responses and the protective ability of an MDCK-cell-derived inactivated H7N9 vaccine in mice.

Jian Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.